OBN Digital Briefing:
A Insight into the National Security and Investment Bill - 
What does it mean for the Life Sciences Industry?'

Thursday 17 December, 10:00 - 11:00

OBN Digital Briefing:
‘An Insight into the National Security and Investment Bill -
What does it mean for the life sciences industry?’

Thursday 17 December, 10:00 - 11:00


The government has put forward it's National Security and Investment Bill to ensure that the government has the necessary powers to scrutinise and invervene in business transactions, such as takeovers and investments that might raise national security issues, while providing businesses and investors with the certainty and trasparency they need to do business in the UK. The new law (and the ongoing consultation on the definition of the sectors that will require mandatory notification) is extremely wide and will have far reaching consequences for the life sciences industry in the UK.

About the event:

The briefing is hosted by Taylor Wessing and will include a 30-minute briefing by Paolo Palmigiano, Head of UK and EU Competition at Taylor Wessing, who will outline what this bill means to life sciences companies in the UK and will be followed by time for audience questions.

This session will be run in a live format using Zoom Webinar, with registration complimentary for both OBN Members and Non-Members. 

About Taylor Wessing:

Taylor Wessing is a global law firm that serves the world's most innovative people and businesses.

Our Life Sciences and Healthcare team work with some of the largest pharmaceutical, biotechnology and medical device companies and healthcare providers in the world to a diverse collection of small-to-medium-sized start-up enterprises ready to up-scale their business, and many companies in between. We guide ambitious global clients within these dynamic and innovative industries through the maze of connected legal, commercial, and regulatory challenges.

For all event enquiries, please contact: events@obn.org.uk.

Processing. Please wait.